108 related articles for article (PubMed ID: 23238481)
1. Antidepressant drugs promote the heterodimerization of the dopamine D2 and somatostatin Sst5 receptors--fluorescence in vitro studies.
Szafran K; Lukasiewicz S; Faron-Górecka A; Kolasa M; Kuśmider M; Solich J; Dziedzicka-Wasylewska M
Pharmacol Rep; 2012; 64(5):1253-8. PubMed ID: 23238481
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants promote formation of heterocomplexes of dopamine D2 and somatostatin subtype 5 receptors in the mouse striatum.
Szafran-Pilch K; Faron-Górecka A; Kolasa M; Żurawek D; Szlachta M; Solich J; Kuśmider M; Dziedzicka-Wasylewska M
Brain Res Bull; 2017 Oct; 135():92-97. PubMed ID: 28987282
[TBL] [Abstract][Full Text] [Related]
3. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis.
Baragli A; Alturaihi H; Watt HL; Abdallah A; Kumar U
Cell Signal; 2007 Nov; 19(11):2304-16. PubMed ID: 17706924
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane.
Dziedzicka-Wasylewska M; Faron-Górecka A; Andrecka J; Polit A; Kuśmider M; Wasylewski Z
Biochemistry; 2006 Jul; 45(29):8751-9. PubMed ID: 16846218
[TBL] [Abstract][Full Text] [Related]
5. Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization.
Łukasiewicz S; Faron-Górecka A; Dobrucki J; Polit A; Dziedzicka-Wasylewska M
FEBS J; 2009 Feb; 276(3):760-75. PubMed ID: 19143836
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor.
Błasiak E; Łukasiewicz S; Szafran-Pilch K; Dziedzicka-Wasylewska M
Pharmacol Rep; 2017 Apr; 69(2):235-241. PubMed ID: 28119185
[TBL] [Abstract][Full Text] [Related]
7. [New medical treatments in pituitary adenomas].
Drutel A; Caron P; Archambeaud F
Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
[TBL] [Abstract][Full Text] [Related]
8. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
Saveanu A; Jaquet P; Brue T; Barlier A
Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.
Dziedzicka-Wasylewska M; Faron-Górecka A; Górecki A; Kuśemider M
Pharmacol Rep; 2008; 60(5):581-7. PubMed ID: 19066405
[TBL] [Abstract][Full Text] [Related]
10. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
Rogoz R; Dziedzicka-Wasylewska M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
[TBL] [Abstract][Full Text] [Related]
11. Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.
Gazi L; López-Giménez JF; Rüdiger MP; Strange PG
Eur J Biochem; 2003 Oct; 270(19):3928-38. PubMed ID: 14511374
[TBL] [Abstract][Full Text] [Related]
12. Neuronal cell lines transfected with the dopamine D2 receptor gene promoter as a model for studying the effects of antidepressant drugs.
Dziedzicka-Wasylewska M; Solich J
Brain Res Mol Brain Res; 2004 Sep; 128(1):75-82. PubMed ID: 15337319
[TBL] [Abstract][Full Text] [Related]
13. Role of silent polymorphisms within the dopamine D1 receptor associated with schizophrenia on D1-D2 receptor hetero-dimerization.
Grymek K; Łukasiewicz S; Faron-Góreckaa A; Tworzydlo M; Polit A; Dziedzicka-Wasylewska M
Pharmacol Rep; 2009; 61(6):1024-33. PubMed ID: 20081237
[TBL] [Abstract][Full Text] [Related]
14. Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse.
Amiri S; Amini-Khoei H; Mohammadi-Asl A; Alijanpour S; Haj-Mirzaian A; Rahimi-Balaei M; Razmi A; Olson CO; Rastegar M; Mehdizadeh M; Zarrindast MR
Physiol Behav; 2016 Sep; 163():107-114. PubMed ID: 27143252
[TBL] [Abstract][Full Text] [Related]
15. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
[TBL] [Abstract][Full Text] [Related]
16. Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance.
Maggio R; Aloisi G; Silvano E; Rossi M; Millan MJ
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S2-7. PubMed ID: 20123551
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum.
Izquierdo-Claros RM; Boyano-Adánez MC; Larsson C; Gustavsson L; Arilla E
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):99-107. PubMed ID: 9221906
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.
Li Y; Zhu ZR; Ou BC; Wang YQ; Tan ZB; Deng CM; Gao YY; Tang M; So JH; Mu YL; Zhang LQ
Behav Brain Res; 2015 Feb; 279():100-5. PubMed ID: 25449845
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
Rogóz Z; Dziedzicka-Wasylewska M
Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
[TBL] [Abstract][Full Text] [Related]
20. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
Ainsworth K; Smith SE; Sharp T
J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
